{
    "2020-09-08": [
        [
            {
                "time": "",
                "original_text": "创新大势下，这些企业有望长期受益",
                "features": {
                    "keywords": [
                        "创新",
                        "企业",
                        "长期受益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "创新企业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(02359)获WuXi AppTec (BVI) Inc.减持约1217.61万股 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "WuXi AppTec"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：WuXi AppTec (BVI) Inc.合计减持1217.61万股 减持数已过半 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "WuXi AppTec"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：WuXi AppTec (BVI) Inc.减持0.51%公司股份 减持股份",
                "features": {
                    "keywords": [
                        "药明康德",
                        "减持",
                        "WuXi AppTec"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：二季度业绩逐步恢复 把握业绩确定性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "二季度",
                        "业绩恢复",
                        "业绩确定性"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德主业毛利率异常下滑 大手笔加码CDMO胜算几何 盈利能力下降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "毛利率下滑",
                        "CDMO",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}